⌘K

Login Start Free

Home/Filings/4/0001213900-17-001939

4//SEC Filing

ORAMED PHARMACEUTICALS INC. 4

Accession 0001213900-17-001939

$ORMPCIK 0001176309operating

View on SEC.gov Company Profile

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 3:06 PM ET

Size

5.5 KB

Accession

0001213900-17-001939

Insider Transaction Report

Form 4

Period: 2017-02-09

ORAMED PHARMACEUTICALS INC.ORMP

Director

Transactions

Award
Stock Option (right to buy)
2017-02-09+12,253→ 12,253 total
Exercise: $1.00Exp: 2027-02-09→ Common Stock (12,253 underlying)

Footnotes (1)

[F1]The Stock Option will vest immediately.

Documents

1 file

4
f4020917li_oramed.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

ORAMED PHARMACEUTICALS INC.

CIK 0001176309

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001176309

Filing Metadata

Form type: 4
Filed: Mar 1, 7:00 PM ET
Accepted: Mar 2, 3:06 PM ET
Size: 5.5 KB

View on SEC.gov